their platelet count and clinical manifestations of thrombo- cytopenia: the aim should be to wean them from this form of treatment as soon as possible and so avoid prolonged immunosuppression in patients who have become stabilised and might well manage better without it.
No takes yet. Share an insight, caveat, or question.
Herman Høst (1981) studied this question.